Stefan R Woroniecki Selected Research

Pollinex Quattro

7/2007	Pollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergy.
7/2004	Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A (MPL) for the treatment of grass pollen allergy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan R Woroniecki Research Topics

Disease

4	Hypersensitivity (Allergy) 07/2007 - 07/2004
1	Seasonal Allergic Rhinitis (Hay Fever) 07/2004

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 07/2007 - 07/2004
2	monophosphoryl lipid AIBA 07/2007 - 07/2004
2	Pollinex QuattroIBA 07/2007 - 07/2004
2	AllergensIBA 02/2006 - 09/2004
1	ragweed pollenIBA 07/2007
1	Immunologic Factors (Immunomodulators)IBA 09/2004
1	Glutaral (Glutaraldehyde)IBA 07/2004
1	Tyrosine (L-Tyrosine)FDA Link 07/2004

Therapy/Procedure

2	Therapeutics 02/2006 - 09/2004